Inductive website screenshot

Inductive

Inductive Bio is a New York-based AI drug discovery company building a virtual lab for small molecule optimization. It pairs medicinal chemists with AI to run millions of in silico ADMET experiments before synthesis. Its Beacon-1 models — trained on a pre-competitive, anonymized data consortium spanning thousands of drug programs — won consecutive first-place finishes in the 2025 Polaris/ASAP and 2026 OpenADMET blind ADMET prediction competitions, beating 370+ submissions including entries from Merck and NVIDIA. Products include the Compass software platform (accessible via API), the Indy AI chemistry assistant, the ADME-One high-throughput profiling service, and Embedded Experts. Founded in 2023 by Josh Haimson and Ben Birnbaum (both formerly Flatiron Health); SOC 2 compliant; backed by Obvious Ventures, a16z Bio+Health, Lux Capital, Bessemer Venture Partners, Character, and S32.

Inductive is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Machine Learning, Drug Discovery, and Biotechnology.

Inductive’s developer surface includes engineering blog and 7 more developer resources.

15.5/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyArtificial IntelligenceMachine LearningDrug DiscoveryBiotechnologyPharmaceuticalsLife SciencesChemistryADMET

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 15.5/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/inductive: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Inductive Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 2

Authentication, authorization, and security posture

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: inductive
name: Inductive
description: Inductive Bio is a New York-based AI drug discovery company building a virtual lab for small molecule optimization.
  It pairs medicinal chemists with AI to run millions of in silico ADMET experiments before synthesis. Its Beacon-1 models
  — trained on a pre-competitive, anonymized data consortium spanning thousands of drug programs — won consecutive first-place
  finishes in the 2025 Polaris/ASAP and 2026 OpenADMET blind ADMET prediction competitions, beating 370+ submissions including
  entries from Merck and NVIDIA. Products include the Compass software platform (accessible via API), the Indy AI chemistry
  assistant, the ADME-One high-throughput profiling service, and Embedded Experts. Founded in 2023 by Josh Haimson and Ben
  Birnbaum (both formerly Flatiron Health); SOC 2 compliant; backed by Obvious Ventures, a16z Bio+Health, Lux Capital, Bessemer
  Venture Partners, Character, and S32.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/67fd80408c022fd8f406c6f7/6803dafa8e9822bfe4e9a943_OpenGraph.jpg
url: https://raw.githubusercontent.com/api-evangelist/inductive/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Artificial Intelligence
- Machine Learning
- Drug Discovery
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Chemistry
- ADMET
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/inductive-domain-security.yml
- type: Website
  url: https://inductive.bio
- type: LLMsTxt
  url: llms/inductive-llms.txt
- type: Conformance
  url: conformance/inductive-conformance.yml
- type: Compliance
  name: SOC 2
  url: https://www.inductive.bio/consortium
- type: GitHubOrganization
  url: https://github.com/inductive-bio
- type: Blog
  url: https://www.inductive.bio/blog
- type: Login
  url: https://app.inductive.bio/login
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence